Adaptive Phase I Studies: The IRB Perspective
In this webinar, IRB member Marilyn Teal reviews why adaptive designs are used and covers areas of special interest when these studies are reviewed by the IRB.
The industry’s choice for
central and local IRB services.
By combining quality reviews with global consulting services, uniquely responsive client service and proprietary, Part 11 compliant technology tools, we are able to both improve human subject protection and allow our clients to reach their business goals.
We've been serving the clinical trial industry since 1983.
Our technology tools deliver unparalleled visibility and efficiency.
We complete thorough, ethical reviews as swiftly as possible.
The Schulman IRB Webinar Series offers timely information to study sponsors, CRO representatives, investigators and institutional personnel in an engaging, easy-to-parse format.
CLICK HERE to see our full webinar archive, as well as to register for upcoming sessions.
In an effort to streamline and clarify organizational processes and policies, Schulman IRB has revised its Recruitment and Study-Related Materials Guidance.Read More
In this recent Applied Clinical Trials e-book, Schulman is recognized for its participation in the Cancer Moonshot 2020 initiative.Read More
To help understand the unique challenges and best practices in conducting medical device clinical trials, it’s important to understand how medical device research is different from other research.Read More
The NPRM outlines changes to the existing federal policy protecting human subjects – the “Common Rule.”Read More